GENMAB A/S - 30 Dec 2025 SCHEDULE 13D/A Report for Merus N.V. Common Shares, Euro 0.09 nominal value per share (MRUS)

Filing Manager: GENMAB A/S
Reporting Manager: Genmab A/S
Security: Merus N.V. Common Shares, Euro 0.09 nominal value per share
Symbol: MRUS
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Filing time: 30 Dec 2025, 17:24:40 UTC
Date of event: 30 Dec 2025
Previous filing: 19 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Genmab A/S	0%	0	0	0	/s/ Jan G. J. van de Winkel	Jan G. J. van de Winkel, President & Chief Executive Officer	0001434265
Genmab Holding II B.V.	0%	0	0	0	/s/ Jan G. J. van de Winkel	Jan G. J. van de Winkel, Authorized Signatory